Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3B | P49841 | 10/20 | 1.00 |
| ▸ | CDK1 | P06493 | 3/20 | 1.00 |
| ▸ | GSK3A | P49840 | 3/20 | 1.00 |
| ▸ | CCNB2 | O95067 | 2/20 | 1.00 |
| ▸ | CCNB1 | P14635 | 2/20 | 1.00 |
| ▸ | CCNB3 | Q8WWL7 | 2/20 | 1.00 |
| ▸ | RPS6KB1 | P23443 | 1/20 | 1.00 |
| ▸ | CDK2 | P24941 | 1/20 | 1.00 |
| ▸ | LIMK1 | P53667 | 1/20 | 1.00 |
| ▸ | TAOK1 | Q7L7X3 | 1/20 | 1.00 |
| ▸ | SLK | Q9H2G2 | 1/20 | 1.00 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 1.00 |
| ▸ | CSNK1G1 | Q9HCP0 | 1/20 | 1.00 |
| ▸ | IDH1 | O75874 | 4/20 | 0.42 |
| ▸ | TMPRSS4 | Q9NRS4 | 1/20 | 0.36 |
| ▸ | ROS1 | P08922 | 1/20 | 0.35 |
| ▸ | CNR1 | P21554 | 1/20 | 0.35 |
| ▸ | CNR2 | P34972 | 1/20 | 0.35 |
| ▸ | KDM1A | O60341 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Laduviglusib SCHEMBL29353709 | 1.00 | GSK3B (1.00) | GSK3BCDK1GSK3ACCNB2CCNB1 | |
| Laduviglusib SCHEMBL29351682 | 1.00 | GSK3B (1.00) | GSK3BCDK1GSK3ACCNB2CCNB1 | |
| Laduviglusib SCHEMBL151139 | 1.00 | GSK3B (1.00) | GSK3BCDK1GSK3ACCNB2CCNB1 | |
| Laduviglusib SCHEMBL30175104 | 0.99 | GSK3B (0.98) | GSK3BCDK1GSK3ACCNB2CCNB1 | |
| Laduviglusib SCHEMBL29468026 | 0.99 | GSK3B (0.98) | GSK3BCDK1GSK3ACCNB2CCNB1 | |
| Laduviglusib SCHEMBL18301565 | 0.99 | GSK3B (0.98) | GSK3BCDK1GSK3ACCNB2CCNB1 | |
| Laduviglusib SCHEMBL29361792 | 0.99 | GSK3B (0.98) | GSK3BCDK1GSK3ACCNB2CCNB1 | |
| Laduviglusib SCHEMBL240280 | 0.87 | GSK3B (0.77) | GSK3BCDK1GSK3ACCNB2CCNB1 | |
| Laduviglusib SCHEMBL29381114 | 0.87 | GSK3B (0.77) | GSK3BCDK1GSK3ACCNB2CCNB1 | |
| Laduviglusib SCHEMBL29838591 | 0.87 | GSK3B (0.77) | GSK3BCDK1GSK3ACCNB2CCNB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 151 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026099481-A1 | METHOD FOR PRODUCING CELLS HAVING AN ACINAR CELL PHENOTYPE | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2026-05-15 | — | — | WO | claimed |
| WO-2025093674-A2 | METHOD FOR EXPANDING LIVER CELLS | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2025-05-08 | — | — | WO | claimed |
| EP-3430132-B1 | GENERATION OF MIDBRAIN-SPECIFIC ORGANOIDS FROM HUMAN PLURIPOTENT STEM CELLS | AGENCY SCIENCE TECH & RES (SG) | 2025-04-30 | — | — | EP | claimed |
| CN-112955141-B | Improved method for inducing tissue regeneration and senescent cell lysis in mammalian cells | AGEX治疗公司 | 2025-02-14 | — | — | CN | claimed |
| EP-4416268-A1 | METHODS FOR PRODUCING CARTILAGE AND BONES | Murdoch Children's Research Institute (AU) | 2024-08-21 | — | — | EP | claimed |
| EP-4412621-A2 | COMPOSITIONS AND METHODS FOR ENHANCED PROTEIN PRODUCTION | HDT Bio Corp. (US) | 2024-08-14 | — | — | EP | claimed |
| CN-109996870-B | Production of midbrain-specific organoids from human pluripotent stem cells | 新加坡科技研究局 | 2024-08-13 | — | — | CN | claimed |
| CN-118355110-A | Method for producing cartilage and bone | 默多克儿童研究所 | 2024-07-16 | — | — | CN | claimed |
| EP-3384007-B1 | IMPROVED METHODS FOR REPROGRAMING NON-PLURIPOTENT CELLS INTO PLURIPOTENT STEM CELLS | BEIHAO STEM CELL AND REGENERATIVE MEDICINE RES INSTITUTE CO LTD (CN) | 2024-03-27 | — | — | EP | claimed |
| WO-2023147009-A1 | CLINICAL-GRADE THERAPEUTIC PROGENITORS GENERATED FROM TANKYRASE/PARP-INHIBITED PLURIPOTENT STEM CELL BANKS | THE JOHNS HOPKINS UNIVERSITY (US) | 2023-08-03 | — | — | WO | claimed |
| CN-116438295-A | Methods and compositions for culturing pluripotent cell suspensions | 生命技术公司 | 2023-07-14 | — | — | CN | claimed |
| CN-110832069-B | Methods for chemically induced lineage reprogramming | 北昊干细胞与再生医学研究院有限公司 | 2023-06-20 | — | — | CN | claimed |
| CN-113423817-B | Compositions and methods for reprogramming non-hepatocytes to hepatocytes | 北京大学 | 2023-05-26 | — | — | CN | claimed |
| EP-4178594-A1 | A METHOD FOR GENERATING A THREE-DIMENSIONAL NEUROMUSCULAR ORGANOID IN VITRO | Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Gemeinschaft (DE) | 2023-05-17 | — | — | EP | claimed |
| EP-4168536-A1 | METHODS AND COMPOSITIONS FOR CULTIVATING PLURIPOTENT CELL SUSPENSIONS | Life Technologies Corporation (US) | 2023-04-26 | — | — | EP | claimed |
| WO-2023060322-A1 | METHODS FOR PRODUCING CARTILAGE AND BONES | MURDOCH CHILDREN'S RESEARCH INSTITUTE (AU) | 2023-04-20 | — | — | WO | claimed |
| WO-2023056202-A2 | COMPOSITIONS AND METHODS FOR ENHANCED PROTEIN PRODUCTION | HDT BIO CORP. (US) | 2023-04-06 | — | — | WO | claimed |
| CN-108431209-B | Derived and mature hepatocyte types of liver stem cells and uses thereof | 新加坡科技研究局 | 2023-02-10 | — | — | CN | claimed |
| CN-108934168-B | Improved methods for reprogramming non-pluripotent cells to pluripotent stem cells | 北昊干细胞与再生医学研究院有限公司 | 2022-05-03 | — | — | CN | claimed |
| US-20220127580-A1 | COMPOSITIONS AND METHODS FOR REPROGRAMING NON-HEPATOCYTE CELLS INTO HEPATOCYTE CELLS | PEKING UNIVERSITY (CN) | 2022-04-28 | — | — | US | claimed |